<DOC>
	<DOCNO>NCT00000353</DOCNO>
	<brief_summary>The purpose study determine efficacy safety buprenorphine/naloxone sublingual tablet formulation office-based therapy opiate dependence treatment .</brief_summary>
	<brief_title>Trial Buprenorphine/Naloxone Opiate Dependence - 2</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Naloxone</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<mesh_term>Buprenorphine , Naloxone Drug Combination</mesh_term>
	<criteria>Please contact site information .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>57 Years</maximum_age>
	<verification_date>December 2002</verification_date>
	<keyword>opiate dependence</keyword>
</DOC>